Amanda Farley1, Paul Aveyard2, Amy Kerr3, Babu Naidu4,3, George Dowswell4. 1. College of Medicine and Dentistry, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. a.c.farley@bham.ac.uk. 2. Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK. 3. Medical Innovation Development Research Unit (MIDRU), Heart of England NHS Foundation Trust, Bordesley Green East, Birmingham, B9 5SS, UK. 4. College of Medicine and Dentistry, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
Abstract
PURPOSE: Evidence suggests that quitting smoking improves symptoms as well as disease-related mortality for cancer patients. However, smoking cessation support is typically not well integrated into routine cancer care even in the case of lung cancer.. We explored surgical lung cancer patients' views about smoking and about their preferences for support to help them to quit. METHODS: We conducted semi-structured, qualitative interviews with 22 surgical lung cancer patients with a smoking history, after treatment with surgery. Data were analysed using the framework approach. RESULTS: Although diagnosis promoted a successful quit attempt in some, others continued smoking or relapsed after a quit attempt. Most participants wished they were a non-smoker but, in conflict with this, also felt that smoking was enjoyable, helped with psychological coping or had some health benefits. Some also demonstrated a fatalist attitude towards the potential detrimental health effects. However, all participants felt that it was important for health professionals to address smoking and some wanted cessation support although it was often not provided. Participants wanted support to start as early as possible and to continue for the first weeks after discharge. CONCLUSIONS: Surgical lung cancer patients often stop smoking during hospitalisation, and many want to remain quit but relapse shortly after discharge. Although it is often not provided, many patients want to be offered support to help them quit. IMPLICATIONS FOR CANCER SURVIVORS: Surveys suggest that clinicians believe that addressing smoking will be difficult and/or unwanted. However, these findings suggest that surgical lung cancer patients would tolerate, and most would prefer, integration of smoking cessation support into routine cancer care.
PURPOSE: Evidence suggests that quitting smoking improves symptoms as well as disease-related mortality for cancer patients. However, smoking cessation support is typically not well integrated into routine cancer care even in the case of lung cancer.. We explored surgical lung cancer patients' views about smoking and about their preferences for support to help them to quit. METHODS: We conducted semi-structured, qualitative interviews with 22 surgical lung cancer patients with a smoking history, after treatment with surgery. Data were analysed using the framework approach. RESULTS: Although diagnosis promoted a successful quit attempt in some, others continued smoking or relapsed after a quit attempt. Most participants wished they were a non-smoker but, in conflict with this, also felt that smoking was enjoyable, helped with psychological coping or had some health benefits. Some also demonstrated a fatalist attitude towards the potential detrimental health effects. However, all participants felt that it was important for health professionals to address smoking and some wanted cessation support although it was often not provided. Participants wanted support to start as early as possible and to continue for the first weeks after discharge. CONCLUSIONS: Surgical lung cancer patients often stop smoking during hospitalisation, and many want to remain quit but relapse shortly after discharge. Although it is often not provided, many patients want to be offered support to help them quit. IMPLICATIONS FOR CANCER SURVIVORS: Surveys suggest that clinicians believe that addressing smoking will be difficult and/or unwanted. However, these findings suggest that surgical lung cancer patients would tolerate, and most would prefer, integration of smoking cessation support into routine cancer care.
Authors: Graham W Warren; James R Marshall; K Michael Cummings; Benjamin Toll; Ellen R Gritz; Alan Hutson; Seyedeh Dibaj; Roy Herbst; Carolyn Dresler Journal: J Thorac Oncol Date: 2013-05 Impact factor: 15.609
Authors: David P Mason; Sreekumar Subramanian; Edward R Nowicki; Joshua D Grab; Sudish C Murthy; Thomas W Rice; Eugene H Blackstone Journal: Ann Thorac Surg Date: 2009-08 Impact factor: 4.330
Authors: Graham W Warren; James R Marshall; K Michael Cummings; Benjamin A Toll; Ellen R Gritz; Alan Hutson; Seyedeh Dibaj; Roy Herbst; James L Mulshine; Nasser Hanna; Carolyn A Dresler Journal: J Oncol Pract Date: 2013-07-29 Impact factor: 3.840
Authors: Elyse R Park; Jamie S Ostroff; Giselle K Perez; Kelly A Hyland; Nancy A Rigotti; Sarah Borderud; Susan Regan; Alona Muzikansky; Emily R Friedman; Douglas E Levy; Susan Holland; Justin Eusebio; Lisa Peterson; Julia Rabin; Jacob Miller-Sobel; Irina Gonzalez; Laura Malloy; Maureen O'Brien; Suhana de León-Sanchez; C Will Whitlock Journal: Contemp Clin Trials Date: 2016-07-19 Impact factor: 2.226
Authors: Amanda Farley; Constantinos Koshiaris; Jason Oke; Ronan Ryan; Lisa Szatkowski; Richard Stevens; Paul Aveyard Journal: Ann Fam Med Date: 2017-09 Impact factor: 5.166
Authors: N Abdelmutti; J Brual; J Papadakos; S Fathima; D Goldstein; L Eng; T Papadakos; G Liu; J Jones; M Giuliani Journal: Curr Oncol Date: 2019-12-01 Impact factor: 3.677
Authors: Sarah Price; Brian Hitsman; Anna Veluz-Wilkins; Sonja Blazekovic; Tarah R Brubaker; Frank Leone; Anita Hole; E Paul Wileyto; Corey Langer; Ravi Kalhan; Jyoti Patel; Robert Schnoll Journal: Psychooncology Date: 2016-05-24 Impact factor: 3.894
Authors: Mary Wells; Patricia Aitchison; Fiona Harris; Gozde Ozakinci; Andrew Radley; Linda Bauld; Vikki Entwistle; Alastair Munro; Sally Haw; Bill Culbard; Brian Williams Journal: BMC Cancer Date: 2017-05-19 Impact factor: 4.430